Target intelligence / Profile preview

TPT1 pseudogene 11 (TPT1P11)

Target
TPT1P11
Molecular classification
Other (Pseudogene)
01

Overview

TPT1 pseudogene 11 (TPT1P11) is classified as a processed pseudogene of the TPT1 gene. Processed pseudogenes are copies of mRNAs that have been reverse-transcribed and integrated back into the genome; they do not encode functional proteins and are generally not transcribed or translated. There is no evidence that TPT1P11 has any biological function, disease association, or therapeutic relevance. Unlike the functional TPT1 gene and its antisense lncRNA (TPT1-AS1), which have documented roles in cancer biology and cell proliferation, TPT1P11 is simply a non-functional genomic element. Pseudogenes are explicitly not considered therapeutic targets, receptors, enzymes, or active participants in biological pathways. No aliases, interacting drugs, or functions are ascribed to TPT1P11 in authoritative genetic databases or literature at this time. TPT1P11 is a pseudogene and not a therapeutic target. It has no known biological roles, mechanisms, or disease associations. Its mention as a drug target or functional molecule is incorrect.

Beyond the preview

Go deeper on TPT1 pseudogene 11 (TPT1P11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TPT1 pseudogene 11 (TPT1P11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call